Mictonet

Propiverine Hydrochloride, the active ingredient in Mictonet, is an antimuscarinic presented as an oral tablet for oral use. It treats overactive bladder symptoms, including urinary urgency, frequency and urge incontinence, in adult patients.

GNH USA supplies Mictonet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is manufactured under strict Good Manufacturing Practice guidelines. Mictonet is distributed under controlled conditions to ensure product integrity throughout the supply chain.

Mictonet, an antimuscarinic agent, is used to manage conditions related to overactive bladder.

Overactive bladder: reduces the frequency of urinary urgency, daytime frequency and episodes of urge incontinence, improving bladder capacity. Urinary urgency: improves the ability to postpone voiding, decreasing the intensity and suddenness of urge sensations. Urge incontinence: decreases involuntary leakage episodes by stabilizing detrusor muscle activity during bladder filling. Nocturia: may lower the number of nighttime voids, helping improve sleep quality.

Propiverine may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Dry mouth - Constipation - Blurred vision - Headache

Serious or Rare Side Effects: - Urinary retention - Severe allergic reaction (anaphylaxis) - Angle‑closure glaucoma

When prescribing Mictonet, clinicians should consider several precautionary measures to minimize risk.

Renal impairment: adjust use in patients with severe renal dysfunction. Hepatic impairment: use with caution in liver disease. Elderly patients: monitor for anticholinergic effects such as confusion or falls. Narrow‑angle glaucoma: avoid in patients with this condition due to risk of increased intra‑ocular pressure. Pregnancy/Breastfeeding: safety not established; use only if benefit outweighs potential risk. Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Propiverine can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase plasma concentrations. - Concomitant use with other anticholinergic agents may exacerbate anticholinergic side effects.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin) may lower effectiveness. - Diuretics may increase the risk of urinary retention. - QT‑prolonging drugs may raise the potential for cardiac arrhythmias.